Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Nguyen NH, Luo J, Paul P, Kim J, Syal G, Ha C, Rudrapatna V, Park S, Parekh N, Zheng K, Sauk JS, Limketkai B, Fleshner P, Eisenstein S, Ramamoorthy S, Melmed G, Dulai PS, Boland BS, Mahadevan U, Sandborn WJ, Ohno-Machado L, McGovern D, Singh S. Nguyen NH, et al. Among authors: rudrapatna v. Clin Gastroenterol Hepatol. 2023 Jan;21(1):173-181.e5. doi: 10.1016/j.cgh.2022.05.008. Epub 2022 May 27. Clin Gastroenterol Hepatol. 2023. PMID: 35644340 Free PMC article.
Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study.
Gu P, Luo J, Kim J, Paul P, Limketkai B, Sauk JS, Park S, Parekh N, Zheng K, Rudrapatna V, Syal G, Ha C, McGovern DP, Melmed GY, Fleshner P, Eisenstein S, Ramamoorthy S, Dulai PS, Boland BS, Grunvald E, Mahadevan U, Ohno-Machado L, Sandborn WJ, Singh S. Gu P, et al. Among authors: rudrapatna v. Am J Gastroenterol. 2022 Oct 1;117(10):1639-1647. doi: 10.14309/ajg.0000000000001855. Epub 2022 Jun 7. Am J Gastroenterol. 2022. PMID: 35973139
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study.
Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai B, Dulai PS, Boland BS, Eisenstein S, Ramamoorthy S, Melmed G, Mahadevan U, Sandborn WJ, Ohno-Machado L. Singh S, et al. Among authors: rudrapatna v. Clin Gastroenterol Hepatol. 2023 Aug;21(9):2359-2369.e5. doi: 10.1016/j.cgh.2022.10.029. Epub 2022 Nov 5. Clin Gastroenterol Hepatol. 2023. PMID: 36343846
Open data informatics and data repurposing for IBD.
Rudrapatna VA, Butte AJ. Rudrapatna VA, et al. Nat Rev Gastroenterol Hepatol. 2018 Dec;15(12):715-716. doi: 10.1038/s41575-018-0050-5. Nat Rev Gastroenterol Hepatol. 2018. PMID: 30061595 Free PMC article.
Creation of an ustekinumab external control arm for Crohn's disease using electronic health records data: A pilot study.
Rudrapatna VA, Cheng YW, Feuille C, Mosenia A, Shih J, Shi Y, Roberson O, Rubin B, Butte AJ, Mahadevan U, Skomrock N, Erondu N, Chehoud C, Rahim S, Apfel D, Curran M, Khan NS, O'Brien C, Terry N, Martini BD. Rudrapatna VA, et al. PLoS One. 2023 Mar 2;18(3):e0282267. doi: 10.1371/journal.pone.0282267. eCollection 2023. PLoS One. 2023. PMID: 36862717 Free PMC article.
35 results